Management of hair loss associated with endocrine therapy in patients with breast cancer: an overview

Endocrine therapy-induced hair loss (ETIHL) associated with aromatase inhibitors and tamoxifen treatment is currently mostly reported but remained an unresolved therapeutic issue in patients with breast cancer (BC) since the number of studies regarding the management is limited in literature. Herein...

Descripción completa

Detalles Bibliográficos
Autores principales: Karatas, Fatih, Sahin, Suleyman, Sever, Ali R., Altundag, Kadri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864803/
https://www.ncbi.nlm.nih.gov/pubmed/27247882
http://dx.doi.org/10.1186/s40064-016-2216-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864803/
https://www.ncbi.nlm.nih.gov/pubmed/27247882
http://dx.doi.org/10.1186/s40064-016-2216-3

Ejemplares similares